Histogen (FRA:CPH) Price-to-Tangible-Book : 0.61 (As of Jun. 14, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Histogen Price-to-Tangible-Book?

As of today (2024-06-14), Histogen's share price is €0.729. Histogen's Tangible Book per Share of Sep. 2023 for the quarter that ended in Sep. 2023 was €1.19. Hence, Histogen's Price to Tangible Book Ratio of today is 0.61.

The historical rank and industry rank for Histogen's Price-to-Tangible-Book or its related term are showing as below:

FRA:CPH' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.24 Med: 0.69 Max: 4.87
Current: 0.24

During the past 4 years, Histogen's highest Price to Tangible Book Ratio was 4.87. The lowest was 0.24. And the median was 0.69.

FRA:CPH's Price-to-Tangible-Book is ranked better than
98.51% of 1212 companies
in the Biotechnology industry
Industry Median: 2.775 vs FRA:CPH: 0.24

A closely related ratio is called PB Ratio. As of today, Histogen's share price is €0.729. Histogen's Book Value per Sharefor the quarter that ended in Sep. 2023 was €1.19. Hence, Histogen's P/B Ratio of today is 0.61.

Histogen Price-to-Tangible-Book Historical Data

The historical data trend for Histogen's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Histogen Price-to-Tangible-Book Chart

Histogen Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Price-to-Tangible-Book

2.04

0.71

0.23

Histogen Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Price-to-Tangible-Book	Get a 7-Day Free Trial													0.35	0.23	0.45	0.33	-

Competitive Comparison of Histogen's Price-to-Tangible-Book

For the Biotechnology subindustry, Histogen's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Histogen's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Histogen's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Histogen's Price-to-Tangible-Book falls into.

Histogen Price-to-Tangible-Book Calculation

Histogen's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Sep. 2023 )
	=	0.729	/	1.192
	=	0.61

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Histogen Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Histogen's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Histogen (FRA:CPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Histogen Inc (FRA:CPH) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

HSTO:USA

Address

10655 Sorrento Valley Road, Suite 200, San Diego, CA, USA, 92121

Website

https://www.histogen.com

Histogen Inc is a clinical-stage therapeutics company focused on developing proprietary hypoxia-generated growth factor technology platforms and stem cell-free biologic products as potential first-in-class restorative therapeutics that ignite the body's natural process to repair and maintain healthy biological function. Under its biologics technology platform, the product candidates in development are HST-003, a treatment for joint cartilage repair, and HST-004, a treatment for spinal disc repair. It also has a pipeline of clinical and preclinical small molecule pan-caspase and caspase selective inhibitors focused on treatments for infectious and inflammatory diseases that the company intends to develop.

Histogen (FRA:CPH) Headlines

No Headlines